Back to Search Start Over

Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate

Authors :
Caroline Andrews
Brian Fortier
Amy Hayward
Ruth Lederman
Lindsay Petersen
Jo McBride
Desiree C. Petersen
Olabode Ajayi
Paidamoyo Kachambwa
Moleboheng Seutloali
Aubrey Shoko
Mamokhosana Mokhosi
Reinhard Hiller
Marcia Adams
Chrissie Ongaco
Elizabeth Pugh
Jane Romm
Tameka Shelford
Frank Chinegwundoh
Ben Adusei
Sunny Mante
Nana Yaa Snyper
Ilir Agalliu
David W. Lounsbury
Thomas Rohan
Alex Orfanos
Yuri Quintana
Judith S. Jacobson
Alfred I. Neugut
Edward Gelmann
Joseph Lachance
Cherif Dial
Thierno Amadou Diallo
Mohamed Jalloh
Serigne Magueye Gueye
Papa Moussa Sène Kane
Halimatou Diop
Anna Julienne Ndiaye
Amina Sow Sall
Ndeye Coumba Toure-Kane
Ezenwa Onyemata
Alash’le Abimiku
Andrew A. Adjei
Richard Biritwum
Richard Gyasi
Mathew Kyei
James E. Mensah
Julian Okine
Vicky Okyne
Isabella Rockson
Evelyn Tay
Yao Tettey
Edward Yeboah
Wenlong C. Chen
Elvira Singh
Michael B. Cook
Christine N. Duffy
Ann Hsing
Cassandra Claire Soo
Pedro Fernandez
Hayley Irusen
Oseremen Aisuodionoe-Shadrach
Abubakar Mustapha Jamda
Peter Oluwole Olabode
Maxwell Madueke Nwegbu
Olalekan Hafees Ajibola
Olushola Jeremiah Ajamu
Yakubu Garba Ambuwa
Akindele Olupelumi Adebiyi
Michael Asuzu
Olufemi Ogunbiyi
Olufemi Popoola
Olayiwola Shittu
Olukemi Amodu
Emeka Odiaka
Ifeoluwa Makinde
Maureen Joffe
Audrey Pentz
Timothy R. Rebbeck
Source :
Journal of Global Oncology, Vol 4, Pp 1-14 (2018)
Publication Year :
2018
Publisher :
American Society of Clinical Oncology, 2018.

Abstract

Purpose: Cancer of the prostate (CaP) is the leading cancer among men in sub-Saharan Africa (SSA). A substantial proportion of these men with CaP are diagnosed at late (usually incurable) stages, yet little is known about the etiology of CaP in SSA. Methods: We established the Men of African Descent and Carcinoma of the Prostate Network, which includes seven SSA centers partnering with five US centers to study the genetics and epidemiology of CaP in SSA. We developed common data elements and instruments, regulatory infrastructure, and biosample collection, processing, and shipping protocols. We tested this infrastructure by collecting epidemiologic, medical record, and genomic data from a total of 311 patients with CaP and 218 matched controls recruited at the seven SSA centers. We extracted genomic DNA from whole blood, buffy coat, or buccal swabs from 265 participants and shipped it to the Center for Inherited Disease Research (Baltimore, MD) and the Centre for Proteomics and Genomics Research (Cape Town, South Africa), where genotypes were generated using the UK Biobank Axiom Array. Results: We used common instruments for data collection and entered data into the shared database. Double-entered data from pilot participants showed a 95% to 98% concordance rate, suggesting that data can be collected, entered, and stored with a high degree of accuracy. Genotypes were obtained from 95% of tested DNA samples (100% from blood-derived DNA samples) with high concordance across laboratories. Conclusion: We provide approaches that can produce high-quality epidemiologic and genomic data in multicenter studies of cancer in SSA.

Details

Language :
English
ISSN :
23789506
Volume :
4
Database :
Directory of Open Access Journals
Journal :
Journal of Global Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.27139994cc564bb6b263811674649fe2
Document Type :
article
Full Text :
https://doi.org/10.1200/JGO.18.00063